MetLife Increases Common Stock Dividend By 4.2%

Business Wire

NEW YORK--(BUSINESS WIRE)--

MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a second quarter 2022 common stock dividend of $0.50 per share, an increase of 4.2% from the first quarter common stock dividend of $0.48 per share. MetLife has increased its common stock quarterly dividend at a 9.5% compound annual growth rate since 2011.

The dividend will be payable on June 14, 2022, to shareholders of record as of May 10, 2022.

Commenting on the announcement, MetLife President and CEO Michel Khalaf said: “We are pleased to increase our common stock quarterly dividend once again. As MetLife continues to invest in profitable growth, this increase reflects our financial strength and our commitment to balanced capital management.”

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements

The forward-looking statements in this news release, such as “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it has no obligation to publicly correct or update any of these statements.

src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20220425006035r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />

View source version on businesswire.com: https://www.businesswire.com/news/home/20220425006035/en/

For Media:

Meredith Hyland
(212) 578-9415

[email protected]

For Investors:
John Hall
(212) 578-7888

[email protected]

Source: MetLife, Inc.